Talisman Energy (NYSE:TLM) was downgraded by analysts at Societe Generale to a “hold” rating in a research report issued to clients and investors on Wednesday. On Friday shares of Talisman Energy Inc. (NYSE:TLM) closed at $7.61. Company’s sales growth for last 5 years was -12.10% and EPS growth for next 5 years is recorded as 5.70%.
Novavax, Inc. (NASDAQ:NVAX) announced that Jill Hoyt has been named Vice President, Human Resources & Administration. Ms. Hoyt joined Novavax in February 2008 as Executive Director, Human Resources & Administration and has been instrumental in the successful growth of the company. Novavax, Inc. (NASDAQ:NVAX) in last trading activity advanced 6.05% to close at $6.31. Company weekly performance is 9.55% while its quarterly performance stands at 43.08%. Novavax, Inc. (NASDAQ:NVAX) is -9.21% away from its 52 week high.
Chinese online game developer Perfect World Co., Ltd. (NASDAQ:PWRD) announced that the special committee of the company’s board of directors has retained China Renaissance Securities (Hong Kong) Ltd. and Duff & Phelps as its financial advisors as well as Skadden, Arps, Slate, Meagher & Flom LLP and Paul Hastings LLP as its legal counsels to review an acquisition proposal. On Friday shares of Perfect World Co., Ltd. (NASDAQ:PWRD) closed at $18.80. Company’s sales growth for last 5 years was 16.30% and EPS growth for next 5 years is recorded as 18.30%.
Polaris Industries Inc. (NYSE:PII) announced plans to build a new production facility in Huntsville, Alabama to provide additional capacity and flexibility as the company continues to experience rapid growth. Located Southwest of Huntsville City Center, the 600,000 square-foot facility will focus on off-road vehicle production. Polaris Industries Inc. (NYSE:PII) in last trading activity decreased -4.74% to close at $145.61. Company weekly performance is -2.16% while its quarterly performance stands at 0.24%. Polaris Industries Inc. (NYSE:PII) is -8.33% away from its 52 week high.
Eli Lilly & Co. (NYSE: LLY) announced its 2015 financial guidance and outlined plans to grow revenue and expand margins through the balance of the decade. The company’s refined strategy will provide greater focus for research and commercial activities and help maintain a sustainable flow of innovative medicines. On last trading day Eli Lilly and Company (NYSE:LLY) decreased -1.33% to close at $69.93. Its volatility for the week is 2.22% while volatility for the month is 2.18%. LLY’s sales growth for past 5 years was 2.60% and its EPS growth for past 5 years was 33.80%. Eli Lilly and Company (NYSE:LLY) monthly performance is -3.16%.